|
|
西宁地区KL-6联合肺间质纤维化CT评分对特发性肺纤维化的诊断价值
|
Abstract:
特发性肺纤维化是原因不明的以普通型间质性肺炎为特征性病理表现的慢性、进行性发展的、预后较差的间质性肺疾病，目前尚缺乏有效的、灵敏度高的无创监测指标。涎液化糖链抗原(KL-6)可反映肺泡损伤，与健康人群对比有显著差异，且KL-6与肺间质纤维化评分有显著正相关，两者联合对于特发性肺间质纤维化具有良好诊断价值。本文拟观察西宁地区特发性肺间质纤维化患者KL-6联合肺间质纤维化评分对该病诊断的临床应用价值。
Idiopathic interstitial lung fibrosis is a chronic, progressive, poorly prognostic interstitial lung dis-ease of unknown cause with common type interstitial pneumonia as the characteristic pathological manifestation, and there is a lack of adequate and sensitive noninvasive monitoring indicators. Sal-ivary liquefied glycocalyx antigen (KL-6) can reflect alveolar damage, and there is a significant dif-ference in comparison with a healthy population. There is a significant positive correlation between KL-6 and interstitial lung fibrosis score, and the combination of the two has a good diagnostic value for idiopathic interstitial lung fibrosis. In this paper, we intend to observe the clinical application value of KL-6 combined with interstitial fibrosis score for the diagnosis of idiopathic interstitial pulmonary fibrosis in the Xining area.
| [1] | 中华医学会呼吸病学分会. 特发性肺(间质)纤维化诊断和治疗指南(草案) [J]. 中华结核合呼吸杂志, 2002, 25(7): 387-389 |
| [2] | Maher, T.M., Oballa, E., Simpson, J.K., Porte, J., Habgood, A., Fahy, W.A., Flynn, A., Molyneaux, P.L., Braybrooke, R., Divyateja, H., Parfrey, H., Rassl, D., Russell, A.M., Saini, G., Renzoni, E.A., Duggan, A.M., Hubbard, R., Wells, A.U., Lukey, P.T., Marshall, R.P. and Jenkins, R.G. (2017) An Epithelial Biomarker Signature for Idiopathic Pulmonary Fibrosis: An Analysis from the Multicentre PROFILE Cohort Study. The Lancet Respiratory Medicine, 5, 946-955. https://doi.org/10.1016/S2213-2600(17)30430-7 |
| [3] | K. Fujimoto, H. Taniguchi, T. Johkoh, Y. Kondoh, K. Ichikado, H. Sumikawa, 罗伟. 急性加重的特发性肺纤维化: HRCT评分预测死亡率[J]. 国际医学放射学杂志, 2012, 35(2): 190. |
| [4] | Ohshimo, S., Ishikawa, N., Horimasu, Y., Hattori, N., Hirohashi, N., Tanigawa, K., Kohno, N., Bonella, F., Guzman, J. and Costabel, U. (2014) Baseline KL-6 Predicts Increased Risk for Acute Exacerbation of Idio-pathic Pulmonary Fibrosis. Respiratory Medicine, 108, 1031-1039. https://doi.org/10.1016/j.rmed.2014.04.009 |
| [5] | Lee, J.S., Lee, E.Y., Ha, Y.-J., Kang, E.H., Lee, Y.J. and Song, Y.W. (2019) Serum KL-6 Levels Reflect the Severity of Interstitial Lung Disease Associated with Connective Tissue Disease. Arthritis Research & Therapy, 21, Article No. 58. https://doi.org/10.1186/s13075-019-1835-9 |
| [6] | Bonella, F., Volpe, A., Caramaschi, P., Nava, C., Ferrari, P., Schenk, K., Ohshimo, S., Costabel, U. and Ferrari, M. (2011) Surfactant Protein Dand KL-6 Serum Levels in Systemic Sclerosis: Correlation with Lung and Systemic Involvement. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 28, 27-33. |
| [7] | Xue, M., Cai, C., Zeng, Y., et al. (2021) Krebs von den Lungen-6 and Surfactant Protein-A in Interstitial Pneumonia with Autoimmune Features. Medicine (Baltimore), 100, e24260. https://doi.org/10.1097/MD.0000000000024260 |
| [8] | Hu, C., Wu, C., Yang, E., et al. (2019) Serum KL-6 Is As-sociated with the Severity of Interstitial Lung Disease in Chinese Patients with Polymyositis and Dermatomyositis. Clin-ical Rheumatology, 38, 2181-2187.
https://doi.org/10.1007/s10067-019-04501-9 |
| [9] | Jiang, D., Xiao, H., Dong, R., Geng, J., Xie, B., Ren, Y. and Dai, H. (2022) Krebs von den Lungen-6 Levels in Untreated Idiopathic Pulmonary Fibrosis. The Clinical Respiratory Journal, 16, 234-243.
https://doi.org/10.1111/crj.13475 |
